Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 81
Appendix C
Statement of Task
An ad hoc planning committee will plan and conduct a public work-
shop that will examine the impact of and investment in the use of genetic
and genomic data in drug development. The workshop will feature presen-
tations and discussions from an array of stakeholders which may include
leaders from academia, industry, and governmental organizations. The goal
of the workshop will be to discuss how genomic and genetic data has been
and will be used in the drug development process to improve aspects such
as target identification, clinical trial design, pharmacogenomics approaches,
biomarker development, and understanding disease biology. The workshop
will also investigate the economic drivers, incentives, and models that use
genomics in drug development. The planning committee will develop the
workshop agenda, select and invite speakers and discussants, and moderate
the discussions. An individually authored summary of the workshop will
be prepared by a designated rapporteur in accordance with institutional
policy and procedures.
81
OCR for page 82
